Aalborg University

aau.dk

Matched: Aalborg University Hospital · Aalborg University

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

372

Active

70

Phase 3

4

Total enrollment

720,961

Pipeline matrix

Showing 12 of 12 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Picoprep—————1
Plenvu—————1
Lithium—————1
Cariprazine—————1
[68Ga]Ga-FAPI-46 PET/CT—————1
vehicle—————2
Local and systemical treatment—————1
Iodine-based contrast agent—————1
Gadolinium-based contrast agent—————1
Delgocitinib cream—————1
lidocaine cream—————1
Lidocaine+Delgocitinib—————1

Next readouts

  • 2024-10-31
  • 2025-12-01
  • 2026-12-31
  • 2027-04-30
  • 2028-03-21
  • 2028-09-01

Top conditions

  • Itch21
  • Healthy18
  • Pain14
  • Low Back Pain11
  • Histamine8
  • Cowhage8
  • Chronic Pain7
  • Heart Failure7

Frequently asked questions about Aalborg University

How many clinical trials does Aalborg University have on ClinicalTrials.gov?
Aalborg University is listed as the lead sponsor on 372 clinical trials in ClinicalTrials.gov, 70 of which are currently active (recruiting, enrolling, or ongoing).
How many of Aalborg University's trials are in Phase 3?
4 of Aalborg University's trials are in Phase 3, spread across 12 active drug programs.
What therapeutic areas does Aalborg University focus on?
Aalborg University's most-studied conditions on ClinicalTrials.gov are Itch, Healthy, Pain, Low Back Pain, Histamine.
When are Aalborg University's next clinical trial readouts?
Aalborg University has 6 upcoming primary-completion readouts tracked here; the soonest is “Incidence of Macular Edema in a Uveitis Population”, expected around 2024-10-31.